Interpace Biosciences Shares Outstanding 2010-2023 | IDXG
Interpace Biosciences shares outstanding from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Interpace Biosciences Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 4 |
| 2022 | 4 |
| 2021 | 4 |
| 2020 | 4 |
| 2019 | 4 |
| 2018 | 3 |
| 2017 | 2 |
| 2016 | 0 |
| 2015 | 0 |
| 2014 | 0 |
| 2013 | 0 |
| 2012 | 0 |
| 2011 | 0 |
| 2010 | 0 |
| 2009 | 0 |
| Interpace Biosciences Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023-12-31 | 4 |
| 2023-09-30 | 4 |
| 2023-06-30 | 4 |
| 2023-03-31 | 4 |
| 2022-12-31 | 4 |
| 2022-09-30 | 4 |
| 2022-06-30 | 4 |
| 2022-03-31 | 4 |
| 2021-12-31 | 4 |
| 2021-09-30 | 4 |
| 2021-06-30 | 4 |
| 2021-03-31 | 4 |
| 2020-12-31 | 4 |
| 2020-09-30 | 4 |
| 2020-06-30 | 4 |
| 2020-03-31 | 4 |
| 2019-12-31 | 4 |
| 2019-09-30 | 4 |
| 2019-06-30 | 4 |
| 2019-03-31 | 4 |
| 2018-12-31 | 3 |
| 2018-09-30 | 3 |
| 2018-06-30 | 3 |
| 2018-03-31 | 3 |
| 2017-12-31 | 2 |
| 2017-09-30 | 2 |
| 2017-06-30 | 1 |
| 2017-03-31 | 0 |
| 2016-12-31 | 0 |
| 2016-09-30 | 0 |
| 2016-06-30 | 0 |
| 2016-03-31 | 0 |
| 2015-12-31 | 0 |
| 2015-09-30 | 0 |
| 2015-06-30 | 0 |
| 2015-03-31 | 0 |
| 2014-12-31 | 0 |
| 2014-09-30 | 0 |
| 2014-06-30 | 0 |
| 2014-03-31 | 0 |
| 2013-12-31 | 0 |
| 2013-09-30 | 0 |
| 2013-06-30 | 0 |
| 2013-03-31 | 0 |
| 2012-12-31 | 0 |
| 2012-09-30 | 0 |
| 2012-06-30 | 0 |
| 2012-03-31 | 0 |
| 2011-12-31 | 0 |
| 2011-09-30 | 0 |
| 2011-06-30 | 0 |
| 2011-03-31 | 0 |
| 2010-12-31 | 0 |
| 2010-09-30 | 0 |
| 2010-06-30 | 0 |
| 2010-03-31 | 0 |
| 2009-12-31 | 0 |
| 2009-09-30 | 0 |
| 2009-06-30 | 0 |
| 2009-03-31 | 0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.007B | $0.040B |
| Interpace Biosciences Inc. is enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services include molecular diagnostic tests, bioinformatics, and pathology services. Pharma services provide pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. Interpace Biosciences Inc., formerly known as INTERPACE DIAGN, is based in PARSIPPANY, NJ. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.048B | 15.56 |
| Cencora (COR) | United States | $47.467B | 18.94 |
| ICON (ICLR) | Ireland | $25.527B | 24.10 |
| DiDi Global (DIDIY) | China | $23.901B | 0.00 |
| Avantor (AVTR) | United States | $17.269B | 23.79 |
| Viatris (VTRS) | United States | $13.856B | 3.96 |
| CochLear (CHEOY) | $13.551B | 0.00 | |
| Revvity (RVTY) | United States | $12.684B | 22.08 |
| Charles River Laboratories (CRL) | United States | $12.333B | 22.48 |
| Medpace Holdings (MEDP) | United States | $12.318B | 40.53 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.750B | 0.00 |
| Natera (NTRA) | United States | $11.049B | 0.00 |
| Solventum (SOLV) | United States | $10.961B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.795B | 50.77 |
| Bausch + Lomb (BLCO) | Canada | $5.236B | 20.14 |
| Organon (OGN) | United States | $4.783B | 4.63 |
| Doximity (DOCS) | United States | $4.461B | 33.21 |
| PACS (PACS) | United States | $3.596B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.228B | 30.00 |
| Sotera Health (SHC) | United States | $3.190B | 15.65 |
| Progyny (PGNY) | United States | $3.133B | 52.58 |
| Life Times (LTH) | United States | $2.882B | 31.85 |
| GoodRx Holdings (GDRX) | United States | $2.749B | 139.20 |
| Premier (PINC) | United States | $2.531B | 9.26 |
| Teladoc Health (TDOC) | United States | $2.325B | 0.00 |
| Agilon Health (AGL) | United States | $2.191B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.167B | 7.01 |
| BrightSpring Health Services (BTSG) | United States | $1.845B | 0.00 |
| Agiliti (AGTI) | United States | $1.374B | 22.44 |
| Establishment Labs Holdings (ESTA) | $1.344B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.328B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.979B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.776B | 8.03 |
| Embecta (EMBC) | United States | $0.627B | 4.14 |
| Auna S.A (AUNA) | Luxembourg | $0.558B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.542B | 0.00 |
| Enhabit (EHAB) | United States | $0.510B | 46.23 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.502B | 0.00 |
| LifeMD (LFMD) | United States | $0.450B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.423B | 0.00 |
| CareDx (CDNA) | United States | $0.413B | 0.00 |
| Beauty Health (SKIN) | United States | $0.389B | 0.00 |
| MultiPlan (MPLN) | United States | $0.375B | 0.00 |
| DocGo (DCGO) | United States | $0.367B | 58.67 |
| ModivCare (MODV) | United States | $0.353B | 4.68 |
| Sera Prognostics (SERA) | United States | $0.326B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.308B | 0.00 |
| Sharecare (SHCR) | United States | $0.277B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.265B | 0.00 |
| Biodesix (BDSX) | United States | $0.145B | 0.00 |
| So-Young (SY) | China | $0.121B | 40.67 |
| Oncology Institute (TOI) | United States | $0.089B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.077B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.053B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.028B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.020B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |